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Abstract
AIM: To compare the histologic features of the liver 
in intrahepatic neonatal cholestasis (IHNC) with infec-
tious, genetic-endocrine-metabolic, and idiopathic eti-
ologies.
METHODS: Liver biopsies from 86 infants with IHNC 
were evaluated. The inclusion criteria consisted of 
jaundice beginning at 3 mo of age and a hepatic biop-
sy during the 1st year of life. The following histologic 
features were evaluated: cholestasis, eosinophilia, gi-
ant cells, erythropoiesis, siderosis, portal fibrosis, and 
the presence of a septum.
RESULTS: Based on the diagnosis, patients were clas-
sified into three groups: group 1 (infectious; n  = 18), 
group 2 (genetic-endocrine-metabolic; n  = 18), and 
group 3 (idiopathic; n  = 50). There were no significant 
differences with respect to the following variables: 
cholestasis, eosinophilia, giant cells, siderosis, portal 
fibrosis, and presence of a septum. A significant dif-
ference was observed with respect to erythropoiesis, 
which was more severe in group 1 (Fisher’s exact test, 
P  = 0.016).
CONCLUSION: A significant difference was observed 
in IHNC of infectious etiology, in which erythropoiesis 
was more severe than that in genetic-endocrine-meta-
bolic and idiopathic etiologies, whereas there were no 
significant differences among cholestasis, eosinophilia, 
giant cells, siderosis, portal fibrosis, and the presence 
of a septum.
© 2009 The WJG Press and Baishideng. All rights reserved.
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INTRODUCTION
The frequency of  cholestatic jaundice is difficult to eval-
uate with certainty, but varies between 1:2500 and 1:5000 
newborns[1-3]. The initial approach in the diagnosis of  
cholestasis is to distinguish between intrahepatic and 
extrahepatic causes, as the latter etiology requires early 
surgical intervention[4]. In general, intrahepatic neonatal 
cholestasis (IHNC) represents 2/3 of  the cases of  neo-
natal cholestasis[5-9]. The most common causes of  IHNC 
are of  infectious origin[10-12]. In septicemia, manifesta-
tions of  hepatic origin represent only one component of  
the involvement of  multiple organs, of  which adequate 
treatment offers the best chance of  recovery[13]. Any se-
rious bacterial infections during the neonatal period can 
result in jaundice[14]; however, there seems to be a more 
frequent association with urinary tract infections, espe-
cially when the pathogen is E. coli[15]. In addition, other 
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infections have been observed, such as syphilis, toxoplas-
mosis, rubella, and cytomegalovirus (CMV)[16-20].
Despite the many possible etiologies for IHNC[5], 
13%-78% of  the cases have been reported to be idio-
pathic[21-24]. Idiopathic IHNC implies that the liver suf-
fers inflammatory alterations of  unknown cause, with no 
evidence of  blockage of  the biliary tree, and infectious 
agents or metabolic errors have been ruled out[1,25,26]. 
There are cases of  idiopathic IHNC which are consid-
ered spontaneous in which there is familial recurrence, 
therefore sporadic cases could possibly consist of  a viral 
injury or another environmental factor that affect the 
transitory form of  the immature liver of  the newborn; 
however, the characteristics are similar in both cases[13,27].
Liver biopsy is currently used to confirm the clinical 
diagnosis and to assess the degree of  necroinflammatory 
injury or fibrosis. Most studies of  percutaneous liver 
biopsy are retrospective analyses and the aim is usually 
to differentiate biliary atresia from neonatal hepati-
tis[12,21,28-32].
There are no data available in the literature pertaining 
to the histologic features present in neonatal hepatitis to 
aid in the differential diagnosis of  IHNC. The objectives 
of  the present study were to analyze and compare the 
histologic features of  the liver in IHNC of  infectious, 
genetic-endocrine-metabolic, and idiopathic etiologies, in 
the search for features which can facilitate the diagnostic 
process.
MATERIALS AND METHODS
Eighty-six patients submitted to liver biopsy during 
IHNC investigation between March 1982 and December 
2005, 72 from the State University of  Campinas Teach-
ing Hospital (UNICAMP) and 14 from the Children’s 
Institute of  the University of  São Paulo (USP). Among 
the 86 hepatic biopsies, 5 were surgical and 81 were per-
cutaneous. The inclusion criteria consisted of  jaundice 
beginning at 3 mo of  age and hepatic biopsy during the 
first year of  life.
In order to establish the etiology of  IHNC, the fol-
lowing were reviewed: serum alpha-1-antitrypsin, sweat 
sodium and chloride test, innate metabolic errors in urine, 
polymerase chain reaction for CMV antigenemia, and 
serology for CMV, human immunodeficiency virus, hepa-
titis B virus (HBV), hepatitis C virus (HCV), Epstein-Barr 
virus, rubella virus, Toxoplasma gondii, and T. pallidum.
Seven histologic variables were evaluated by means 
of  an investigation protocol: cholestasis, eosinophilia 
in the inflammatory infiltrate, presence of  giant cells, 
erythropoiesis, siderosis, portal fibrosis and the presence 
of  a septum. Siderosis and cholestasis were evaluated by 
Perls’ staining and portal fibrosis and the presence of  a 
septum by Masson staining.
The histologic variables (cholestasis, eosinophilia in 
the inflammatory infiltrate, presence of  giant cells, eryth-
ropoiesis, siderosis and portal fibrosis) were classified ac-
cording to the degree of  intensity using a grading system 
(Table 1). The histologic variable, septum was classified 
by: presence or absence.
Ethical aspects
The present research study was approved by the medi-
cal research ethics committees of  both institutions. In-
formed consent was not required because liver biopsies 
were performed during the course of  clinical evaluation.
Statistical analysis
In order to verify associations between categorical 
variables, the c2 test was used. When the expected values 
were < 5, the Fisher’s exact test was used[33]. Significance 
was established as P ≤ 0.05 in all tests. The computer 
software used was SAS for Windows, version 8.02 (SAS 
Institute Inc., Cary, NC, USA).
RESULTS
Based on the etiology of  IHNC, the patients were clas-
sified into three groups: group 1 (infectious; n = 18), 
group 2 (genetic-endocrine-metabolic; n = 18), and 
group 3 (idiopathic; n = 50). The etiologies of  IHNC are 
presented in Table 2.
Twenty-seven patients were females and 59 were 
males. Patients were predominantly boys in all 3 groups (P 
= 0.407).
The mean age at the time of  liver biopsy was as fol-
lows: group 1, 2 mo and 15 d (range, 1-6 mo and 9 d); 
group 2, 2 mo and 15 d (range, 1-6 mo and 8 d); and 
group 3, 2 mo and 24 d (range, 13 d-9 mo and 5 d). 
There were no statistical differences among the groups 
(P = 0.428).
Table 3 shows values for birth weight, weight during 
the first medical visit and stature at birth for the groups. 
There were no significant differences among the groups 
according to the variables: weight during the first medi-
cal visit and stature at birth. However, a significant dif-
ference was observed for birth weight, which was lower 
in group 1 in relation to groups 2 and 3 (P = 0.014).
The degree of  cholestasis was not significantly dif-
ferent between the 3 groups studied (P = 0.078; Figure 
1A). The presence of  giant cells, graded as absent, mild, 
moderate, and severe in groups 1, 2, and 3 did not show 
any significant differences (P = 0.144; Figure 1B).
The presence of  eosinophils in the inflammatory 
infiltrate did not differ when the genetic-endocrine-
metabolic and/or idiopathic groups were compared (P = 
0.056; Figure 1C). A significant difference was observed 
for to the variable, erythropoiesis in group 1 (P < 0.05; 
Figure 1D).
With respect to siderosis, there was no correlation 
with the etiology of  IHNC (P = 0.973; Figure 1E).
With respect to progression of  IHNC to chronic 
stages, portal fibrosis (Fisher’s exact test P = 0.86) and 
the presence of  a septum (c2 = 3.83; P = 0.147) were not 
related to the etiology of  IHNC (Figure 1F and G).
DISCUSSION
Liver biopsy is recommended for the diagnosis of  cho-
lestasis of  unknown etiology. The interpretation of  a 
single liver biopsy in a child with neonatal cholestasis is 
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limited by the dynamics of  the disease. Interpretation 
of  the biopsy findings is pathologist-dependent and re-
quires experience[4,33].
Most studies involving percutaneous liver biopsies 
are retrospective analyses, using the clinical course, surgi-
cal or autopsy results as a gold standard. However, the 
goal is usually to differentiate biliary atresia from neona-
tal hepatitis[21,28-32].
Many cholestatic conditions are expressed differently 
with time. Liver biopsy can also provide disease-specific 
findings. Examples include PAS-positive granules in al-
pha-1 antitrypsin deficiency, paucity of  ducts in Alagille 
syndrome, necroinflammatory duct lesions in sclerosing 
cholangitis, and other findings that are relatively specific 
for metabolic and storage diseases[4,34,35].
Hepatic erythropoiesis was more evident in INHC 
of  infectious etiology. This was not clear in the idiopath-
ic group, which was likely due to the participation of  an 
undetected infectious agent. On the other hand, hepatic 
erythropoiesis strongly suggests an infection.
Fetal hematopoiesis has an onset in the beginning of  
gestation. Initially, hematopoiesis is restricted to the vi-
telline bag up to the gestational age of  6-8 wk, when the 
liver starts to be the predominant organ of  production. 
At 20 wk, the bone marrow becomes the main organ of  
hematopoiesis and remains as the primary reservoir for 
the circulating population of  immune cells. However, 
when there are infectious processes, hepatic production 
persists[34].
The presence of  eosinophilia in the inflammatory in-
filtrate, an important marker of  neonatal hepatitis[35], did 
not show significant differences when compared to the 
genetic-endocrine-metabolic and/or idiopathic groups. 
The degree of  cholestasis, a morphologic variable, which 
is extremely important for the differential diagnosis of  
extra- and intra-hepatic cholestasis, did not show a sig-
nificant difference between the 3 patient groups. Similar 
findings were observed in relation to progression to 
chronic stages, demonstrating that portal fibrosis or a 
septum is not related to the etiology of  the process. In 
relation to siderosis and the presence of  giant cells, our 
findings did not demonstrate any correlation with the 
etiology of  IHNC.
In conclusion, there are no data available in the 
literature analyzing the histologic features usually pres-
ent in neonatal hepatitis in the differential diagnosis of  
IHNC. There were no significant differences among 
different etiologies of  IHNC in relation to the following 
histologic features: cholestasis, eosinophilia, giant cells, 
portal fibrosis, the presence or absence of  a septum, and 
siderosis. A significant difference was observed in IHNC 
of  infectious etiology, which presented with more severe 
www.wjgnet.com
Table 1  Grading system used for histological parameters: cholestasis, eosinophilia in the inflammatory infiltrate, presence of giant 
cells, erythropoiesis, siderosis, and portal fibrosis
Mild Moderate Severe
Cholestasis Biliary pigment deposits in 
few hepatocytes of zone 3 
acini
Hepatocytes with biliary pigment in two 
zone 3 acini associated with the presence 
of rare canalicular bilirubinostasis
The majority of the hepatocytes with biliary pigment 
biliary associated with several canalicular bilirubi-
nostasis
Eosinophilia in the 
inflammatory infiltrate
Rare eosinophils in few 
space-porta
Some eosinophils in many space-porta 
and rare in the parenchyma
Many eosinophils in all the space-porta and several 
in the parenchyma
Presence of giant cells Occurring in a maximum of 
30% of the hepatocytes
Between 30% and 60% of the hepatocytes > 60% of the hepatocytes
Erythropoiesis  Rare groupings of erythro-
blasts
Some groupings of erythroblasts Groupings of erythroblasts and megakaryocytes
Siderosis Deposits of ferric pigment in 
only a few Kupffer cells
Deposits of ferric pigment in Kupffer cells 
and a few hepatocytes
Deposits of ferric pigment in the majority of Kupffer 
cells and many hepatocytes
Portal fibrosis Discrete widening of some 
space-porta
Widening of some space-porta Widening of all space-porta
Table 2  Etiologies of intrahepatic neonatal cholestasis
Groups Etiology Number of cases
1 Neonatal sepsis   6
Cytomegalovirus   6
Urinary tract infection   3
Syphilis   1  
Toxoplasmosis   2
2 Alpha1-antitripsyn deficiency   2
Other metabolic diseases   6
Galactosemia   2
Alagille Syndrome   2
Byler’s Disease   1
Cystic Fibrosis   1
Secondary to use of parenteral nutrition   1
Down’s Sindrome   1
Panhypopituitarism   2
3 Idiopathic 50
Total 86
Table 3  Clinical characteristics of the patients during the 
first evaluation, in accordance with groups 1 (infectious), 2 
(genetic-endocrine-metabolic) and 3 (idiopathic)
Group 1 Group 2 Group 3 P
Birth weight (g) 2160 2780 2750 0.014
(SD = 650) (SD = 594) (SD = 767)
Weight during the 
first medical visit (g)
3040 3567 3970 0.105
(SD = 1014) (SD = 1170) (SD = 1074)
Stature at birth (cm)        44.5     47     48 0.373
(SD = 4.26) (SD = 3.51) (SD = 5.22)
A significant difference was observed for birth weight, which was lower in 
group 1 in relation to groups 2 and 3 (P < 0.05).
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Figure 1  Results of analysis of histologic features present in intrahepatic neonatal cholestasis (IHNC). A: Cholestasis: there was no significant difference 
between the 3 groups studied (P > 0.05); B: Giant cells: there was no significant difference between the 3 groups studied (P > 0.05); C: Eosinophils: there was no 
significant difference between the 3 groups studied (P > 0.05); D: Erythropoiesis: there was a significant difference in group 1 (P < 0.05); E: Siderosis: there was no 
significant difference between the 3 groups studied (P > 0.05); F: Portal fibrosis (graded as absent, mild, moderate, and severe): there was no significant difference 
between the 3 groups studied (P > 0.05); G: Septum (graded as absent or present) in groups 1 (infectious), 2 (genetic-endocrine-metabolic) and 3 (idiopathic): there 
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erythropoiesis than the genetic-endocrine-metabolic and 
idiopathic etiologies.
In the present study, erythropoiesis was more severe 
in cases of  infectious etiology than in genetic-endocrine-
metabolic and idiopathic etiologies and should prompt 
an investigation for infection.
COMMENTS
Background
Seven histologic variables were evaluated in 86 patients submitted to liver bi-
opsy during intrahepatic neonatal cholestasis (IHNC) investigation: cholestasis, 
eosinophilia in the inflammatory infiltrate, presence of giant cells, erythropoi-
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philia in the inflammatory infiltrate, presence of giant cells, erythropoiesis, sid-
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of IHNC.
Applications 
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Terminology
Cholestasis, eosinophilia in the inflammatory infiltrate, presence of giant cells, 
erythropoiesis, siderosis, portal fibrosis and the presence of a septum are histo-
logic features usually present in neonatal hepatitis. A scoring system for these 
histologic features was used in the differential diagnosis of IHNC.
Peer review
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REFERENCES
1 Balistreri WF. Neonatal cholestasis. J Pediatr 1985; 106: 
171-184
2 Danks DM. Management of neonatal obstructive jaundice. 
Aust Paediatr J 1977; 13: 71-76
3 Dick MC, Mowat AP. Hepatitis syndrome in infancy--an 
epidemiological survey with 10 year follow up. Arch Dis 
Child 1985; 60: 512-516
4 Moyer V, Freese DK, Whitington PF, Olson AD, Brewer 
F, Colletti RB, Heyman MB. Guideline for the evaluation 
of cholestatic jaundice in infants: recommendations of the 
North American Society for Pediatric Gastroenterology, 
Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2004; 
39: 115-128
5 Dellert SF, Balistreri WF. Neonatal cholestasis. In: Walker 
WA, Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB, 
editors. Pediatric Gastrointestinal Disease. 3rd ed. Canada: 
B.C. Decker, 2000: 880-894
6 Fischler B, Papadogiannakis N, Nemeth A. Aetiological 
factors in neonatal cholestasis. Acta Paediatr 2001; 90: 88-92
7 Henriksen NT, Drablos PA, Aagenaes O. Cholestatic 
jaundice in infancy. The importance of familial and genetic 
factors in aetiology and prognosis. Arch Dis Child 1981; 56: 
622-627
8 Mowat AP. Hepatite e colestase em lactentes: Afecções 
intra-hepáticas. In: Mowat AP, editor. Doenças Hepáticas 
em Pediatria. 2nd ed. Rio de Janeiro: Revinter, 1991: 41-80
9 Yachha SK, Sharma A. Neonatal cholestasis in India. Indian 
Pediatr 2005; 42: 491-492
10 Silveira TR, Pires ALG. Icterícia colestática neonatal. In: 
Gastroenterologia Pediátrica. 2nd ed. Edição.Rio de Janeiro: 
Guanabara, 1991: 465-687
11 Prado ET, Araujo Mde F, Campos JV. [Prolonged neonatal 
cholestasis: prospective study] Arq Gastroenterol 1999; 36: 
185-194
12 Zerbini MC, Gallucci SD, Maezono R, Ueno CM, Porta 
G, Maksoud JG, Gayotto LC. Liver biopsy in neonatal 
cholestasis: a review on statistical grounds. Mod Pathol 1997; 
10: 793-799
13 Bezerra JA. Colestase neonatal. In: Ferreira CT, Carvalho 
E, Silva LR, editors. Gastroenterologia e hepatologia em 
pediatria. Rio de Janeiro São Paulo Belo Horizonte: Medsi, 
2003: 582-597 
14 Tiker F, Tarcan A, Kilicdag H, Gurakan B. Early onset 
conjugated hyperbilirubinemia in newborn infants. Indian J 
Pediatr 2006; 73: 409-412
15 Garcia FJ, Nager AL. Jaundice as an early diagnostic sign 
of urinary tract infection in infancy. Pediatrics 2002; 109: 
846-851
16 American Academy of Pediatrics . Cytomegalovirus 
infection. In: Pickering LK. Redbook 2003: report of the 
Committee on Infectious Diseases. 26th ed. Elk Grove 
Village (IL): American Academy of Pediatrics, 2003: 259-262
17 Felber S, Sinatra F. Systemic disorders associated with 
neonatal cholestasis. Semin Liver Dis 1987; 7: 108-118
18 Munro SC, Hall B, Whybin LR, Leader L, Robertson P, 
Maine GT, Rawlinson WD. Diagnosis of and screening 
for cytomegalovirus infection in pregnant women. J Clin 
Microbiol 2005; 43: 4713-4718
19 Roberts EA. A criança ictérica. In: Kelly DA. Doenças 
hepáticas e do sistema biliar em crianças. São Paulo: Livraria 
Santos Editora, 2001: 11-45
20 Shibata Y, Kitajima N, Kawada J, Sugaya N, Nishikawa K, 
Morishima T, Kimura H. Association of cytomegalovirus 
with infantile hepatitis. Microbiol Immunol 2005; 49: 771-777
21 Dehghani SM, Haghighat M, Imanieh MH, Geramizadeh B. 
Comparison of different diagnostic methods in infants with 
Cholestasis. World J Gastroenterol 2006; 12: 5893-5896
22 Eliot N, Odievre M, Hadchouel M, Hill C, Flamant R. 
[Statistical analysis of clinical, biological and histologic data 
in 288 cases of neonatal cholestasis] Arch Fr Pediatr 1977; 34: 
CCXIII-CCXX
23 Hessel G, Yamada RM, Escanhoela CA, Bustorff-Silva JM, 
Toledo RJ. [The role of the abdominal ultrasonography and 
percutaneous liver biopsy in the differential diagnosis of 
neonatal cholestasis] Arq Gastroenterol 1994; 31: 75-82
24 Mieli-Vergani G, Howard ER, Mowat AP. Liver disease in 
infancy: a 20 year perspective. Gut 1991; Suppl: S123-S128
25 Wang JS, Tan N, Dhawan A. Significance of low or normal 
serum gamma glutamyl transferase level in infants with 
idiopathic neonatal hepatitis. Eur J Pediatr 2006; 165: 795-801
26 Balistreri WF, Heubi JE, Suchy FJ. Immaturity of the 
enterohepatic circulation in early life: factors predisposing 
to “physiologic” maldigestion and cholestasis. J Pediatr 
Gastroenterol Nutr 1983; 2: 346-354
27 Balistreri WF, Bezerra JA. Whatever happened to “neonatal 
hepatitis”? Clin Liver Dis 2006; 10: 27-53, v
28 Brough AJ, Bernstein J. Conjugated hyperbilirubinemia in 
early infancy. A reassessment of liver biopsy. Hum Pathol 
1974; 5: 507-516
29 Landing BH , Wells TR, Ramicone E. Time course of 
www.wjgnet.com
 COMMENTS
482     ISSN 1007-9327     CN 14-1219/R      World J Gastroenterol      January 28, 2009     Volume 15     Number 4
the intrahepatic lesion of extrahepatic biliary atresia: a 
morphometric study. Pediatr Pathol 1985; 4: 309-319
30 Fox VL, Cohen MB, Whitington PF, Colletti RB. Outpatient 
liver biopsy in children: a medical position statement of t
he North American Society for Pediatric Gastroenterology 
and Nutrition. J Pediatr Gastroenterol Nutr 1996; 23: 213-216
31 Santos JL, Almeida H, Cerski CT, Silveira TR. Histo-
pathological diagnosis of intra- and extrahepatic neonatal 
cholestasis. Braz J Med Biol Res 1998; 31: 911-919
32 Okcu-Heper A, Erden E, Doganci T, Kuloglu Z, Kansu 
A, Genc Y. Nonobstructive neonatal cholestasis: clinical 
outcome and scoring of the histopathological changes in 
liver biopsies. Pediatr Dev Pathol 2006; 9: 44-51
33 Russo P. Liver including tumors, gallbladder, and biliary 
tree. In: Gilbert-Barnes E. Potter’s Pathology of the fetus, 
infant and Child. Salt Lake City: Mosby Elsevier, 2007: 
1207-1268
34 Bazlul Karim A, Kamal M. Cholestatic jaundice during 
infancy: experience at a tertiary-care center in Bangladesh. 
Indian J Gastroenterol 2005; 24: 52-54
35 Matthai J, Paul S. Evaluation of cholestatic jaundice in 
young infants. Indian Pediatr 2001; 38: 893-898
S- Editor  Li DL    L- Editor  Webster JR    E- Editor  Ma WH
www.wjgnet.com
Bellomo-Brandao MA et al . Histology in IHNC                                             483
